Francis Drobniewski
Tuberculosis, HIV seroprevalence and intravenous drug abuse in prisoners
King's College London
high rates tuberculosis tb hiv believed exist russian prisons prisoners tb studied order identify following 1 prevalence hiv risk factors hiv bloodborne virus infections 2 clinical social factors might compromise tb treatment effectiveness andor patient adherence hence encourage treatment failure 1yr crosssectional prevalence study 1345 prisoners tb conducted inpatient tb facility samara russian federation hiv hepatitis b andor c coinfection occurred 122 241 prisoners respectively rates significantly higher civilians overall 486 prisoners used drugs 883 intravenous users prisoners likely intravenous drug users hiv positive compared civilians tb 402 prisoners shared needles twothirds prisoners 686 received previous tb drug therapy frequently multiple interrupted courses significantly likely civilians previous therapy consistent high drugresistance rates seen prisons major drivers tuberculosis hiv epidemics novel strategies needed reduce spread blood borne diseases particularly intravenous drug users